(Q51826519)

13 April 2018

title

Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes? (English)

1 reference

13 April 2018

author name string

Arthur A Caire

1

1 reference

13 April 2018

Leon Sun

2

1 reference

13 April 2018

Oludotun Ode

3

1 reference

13 April 2018

Danielle A Stackhouse

4

1 reference

13 April 2018

Kelly Maloney

5

1 reference

13 April 2018

Craig Donatucci

6

1 reference

13 April 2018

Vladimir Mouraviev

7

1 reference

13 April 2018

Thomas J Polascik

8

1 reference

13 April 2018

Cary N Robertson

9

1 reference

13 April 2018

David M Albala

10

1 reference

13 April 2018

Judd W Moul

11

1 reference

13 April 2018

language of work or name

English

0 references

publication date

7 June 2009

1 reference

13 April 2018

published in

Urology

1 reference

13 April 2018

volume

74

1 reference

13 April 2018

issue

3

1 reference

13 April 2018

page(s)

643-647

1 reference

13 April 2018

Natural history of progression after PSA elevation following radical prostatectomy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: results from the SEARCH database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Positive surgical margins during robotic radical prostatectomy: a contemporary analysis of risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Changing nature of high risk patients undergoing radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

The Long-Term Clinical Impact of Biochemical Recurrence of Prostate Cancer 5 or More Years After Radical Prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Changes in prognostic significance and predictive accuracy of Gleason grading system throughout PSA era: impact of grade migration in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Robotic laparoscopic radical prostatectomy for biopsy Gleason 8 to 10: prediction of favorable pathologic outcome with preoperative parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.02.049

10.1016/J.UROLOGY.2009.02.049

7 January 2021

Identifiers

DOI

1 reference

13 April 2018

1 reference

13 April 2018